Wird geladen...
FGF21 in Obesity and Cancer: New Insights
The endocrine FGF21 was discovered as a novel metabolic regulator in 2005 with new functions bifurcating from the canonic heparin-binding FGFs that directly promote cell proliferation and growth independent of a co-receptor. Early studies have demonstrated that FGF21 is a stress sensor in the liver...
Gespeichert in:
| Veröffentlicht in: | Cancer Lett |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779663/ https://ncbi.nlm.nih.gov/pubmed/33264641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2020.11.026 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|